The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.
Autoimmune Disease Diagnostics Market Report Highlights
- Localized autoimmune disease diagnostics was the largest segment in 2015 owing to high usage for type 1 diabetes and idiopathic thrombocytopenic purpura
- Type 1 diabetes is estimated to grow at a significant growth rate of over 4.0% in the localized disease type segment
- Systemic disease diagnostics is anticipated to witness lucrative CAGR of around 5.0% over the forecast period due to increasing R&D for the development of novel diagnostic biomarkers for the treatment of rheumatoid arthritis and systemic lupus erythematosus
- Rheumatoid arthritis is one of the most recurring autoimmune disorders further demanding a high amount of rapid diagnostics for exploring better alternative treatments
- North America was the largest regional market in 2015. The high market penetration rate of technologically advanced products and increased lab automation rate are some of the factors contributing to its large share
- Asia Pacific region is anticipated to grow at the fastest CAGR of above 4.0% over the forecast period owing to increasing focus on type 1 diabetes diagnosis
Gain deeper insights on the market and receive your free copy with TOC now @: http://www.grandviewresearch.com/industry-analysis/autoimmune-disease-diagnostics-industry
Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks healthy tissues and organs in the body, leading to inflammation and damage. Diagnosing autoimmune diseases can be challenging as symptoms can vary widely and often overlap with other conditions. Therefore, physicians use a combination of patient history, physical examination, and laboratory tests to diagnose autoimmune diseases. Blood tests that detect autoantibodies, which are antibodies that mistakenly target the body’s own tissues, are commonly used for diagnostic purposes. Additionally, imaging tests such as X-rays, computed tomography (CT), and magnetic resonance imaging (MRI) can help in diagnosing and monitoring autoimmune diseases. Ultimately, early and accurate diagnosis of autoimmune diseases is crucial for effective treatment and management of the condition.
It is expected to grow significantly in the coming years due to the increasing prevalence of autoimmune diseases, advancements in diagnostic technologies, and rising awareness about early disease detection. Technological advancements, such as the development of new biomarkers and the use of point-of-care testing devices, are expected to drive the growth of the autoimmune disease diagnostics market in the coming years. Additionally, the increasing demand for personalized medicine and the growing use of autoantibody tests for disease diagnosis and monitoring are expected to further boost the market growth.
Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.
Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.
Autoimmune Disease Diagnostics Market Insights By Region
North America held the largest market share, majorly due to the introduction of the Affordable Care Act, the presence of favorable regulations & initiatives undertaken by the AARDA, and high disease prevalence in the region. These initiatives aim to curb healthcare spending by diagnosing diseases at an early stage and elevating patient awareness levels. Asia Pacific region is expected to witness lucrative growth due to constantly improving healthcare infrastructure, growing patient awareness levels, and the presence of high unmet patient needs. It is expected to experience an increase in revenue share during the forecast period.
Competitive Analysis By Major Players
The market is consolidated in nature, therefore is marked by the presence of extensive mergers and acquisitions. The development of novel products for efficient and rapid diagnosis is a key strategy undertaken by the majority of key players. Some key players of this market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU.Diagnostics GmbH & Co. KG; INOVA Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.
For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/autoimmune-disease-diagnostics-industry/request/rs43
Grand View Research has segmented the autoimmune disease diagnostics market by type and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/autoimmune-disease-diagnostics-industry
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com